GENEVA, Aug. 31 -- HARBIN HONGDOUSHAN BIO-PHARM CO., LTD. filed a patent application (CN2025/078954) for “MARINE SODIUM POLYSACCHARIDE, METHOD FOR PREPARING SAME, USE THEREOF, AND ANTICOAGULANT AND/OR ANTITHROMBOTIC MEDICAMENT TARGETING INTRINSIC COAGULATION PATHWAY”. With publication no. WO/2026/174607, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C08B 37/08
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....